Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 163
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 61
Pharmaceuticals 50
Drug Discovery 48
Cardiovascular Drugs 46
Biopharmaceuticals 43
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 28
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,028 Results (Page 13 of 52)
- Relevance
  Sort by

Living Biological Drugs Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3419EUR$3,939USD£2,964GBP

CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi, Carvykti, Kymriah), Disease Indication (Lymphoma, Leukemia, Multiple Myeloma), End-use, Region and Segment Forecasts, 2025-2030

 Report
May 2025
90 Pages
Global

From

€5165EUR$5,950USD£4,478GBP

Human Respiratory Syncytial Virus Treatment Market - Global Forecast 2025-2030

 Report
August 2025
197 Pages
Global

From

€3419EUR$3,939USD£2,964GBP

OTC Drug and Dietary Supplement Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3897EUR$4,490USD£3,379GBP

Respiratory Syncytial Virus Therapeutic Drugs Market - Global Forecast 2025-2030

 Report
August 2025
185 Pages
Global

From

€3419EUR$3,939USD£2,964GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cell Therapy Market 2025-2029

 Report
July 2025
218 Pages
Global

From

€2170EUR$2,500USD£1,881GBP

US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028

 Report
July 2023
3600 Pages
United States

From

€5078EUR$5,850USD£4,402GBP

€7812EUR$9,000USD£6,773GBP

Healthcare Digital Marketing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Technology, Type of Product, End User, and Key Geographical Regions

 Report
March 2025
177 Pages
Global

From

€4166EUR$4,799USD£3,612GBP

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
307 Pages
Global

From

€2170EUR$2,500USD£1,881GBP

Pharmaceutical Pellets Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3897EUR$4,490USD£3,379GBP

Biologics Market - Forecasts from 2024 to 2029

 Report
April 2024
121 Pages
Global

From

€3429EUR$3,950USD£2,973GBP

Global Cell Based Immunotherapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
110 Pages
Global

From

€4123EUR$4,750USD£3,575GBP

Oncology Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem and Application - Analysis and Forecast, 2020-2031

 Report
March 2022
273 Pages
Global

From

€2279EUR$2,625USD£1,975GBP

€4557EUR$5,250USD£3,951GBP

Kaposi Sarcoma Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3419EUR$3,939USD£2,964GBP

Immuno-Oncology Market - Global Forecast 2026-2032

 Report
January 2026
197 Pages
Global

From

€3419EUR$3,939USD£2,964GBP

Pharmaceutical API Manufacturing Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3897EUR$4,490USD£3,379GBP

United States Regenerative Medicine Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F

 Report
August 2025
85 Pages
United States

From

€3038EUR$3,500USD£2,634GBP

Cancer biologics Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3897EUR$4,490USD£3,379GBP

Primary Sclerosing Cholangitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1302EUR$1,500USD£1,129GBP

Hepatitis C Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
87 Pages
Global

From

€3200EUR$3,949USD£2,871GBP

1,028 Results (Page 13 of 52)
- 1
- 11
- 12
- 13
- 14
- 15

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.